Google parent company shopping around shoes that track weight and falls

Amy Baxter | | Health Exec | Digital Transformation
sport-shoe-1470061_1920.jpg

Verily, the life sciences business of Google parent company Alphabet, has a new prototype for shoes enabled with sensors that can help track weight, falls and movement, according to CNBC.

Verily has reportedly been looking for partners to develop the shoes, showing a prototype in private meetings in the hopes of bringing them to market, three people familiar with the project told CNBC.

The project is the latest example of the arms race in digital health from major companies, such as Apple and Amazon. Verily’s Study Watch recently earned FDA clearance for its electrocardiogram (ECG) feature. The Alphabet subsidiary also raised $1 billion in an investment round at the start of the year.

See the full story below:

Alphabet’s Verily has been working on health-tracking shoes to measure movement…

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

5 ways AI can help make healthcare more affordable for everyone
HIMSS survey report: Beware insider threats to cybersecurity involving AI
Primary care is primed for AI. But is AI aligned with primary care?
Machine learning vs. bodily pain: 5 points of promise and challenge
Generative AI isn’t changing everything for patients and providers—but it’s not leaving much unaffected, either
Antibiotics prescriptions: There’s a large-language model for that

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.